TECH financials
Bio-Techne Corporation · end-of-day data as of Oct 16, 2026
Bio-Techne Corporation
$72.57+1.5%
Hold · 13 analystsPT $67.46 -7.0%
TECH reported revenue of $321M for the quarter ended Jun 30, 2026 (Q4 FY2026), up 1.3% from a year earlier. It posted diluted EPS of $0.36, free cash flow of $86.94M and a net margin of 17.0%.
Valuation
- P/E62.6x
- P/E vs own-31.5%
- P/E vs sector+122.2%
- FCF yield+2.3%
- Market cap$11.38B
Quarterly results
Q4 FY2026: Revenue +1.3% year over year, free cash flow 27.1% of revenue, operating margin 23.1%.
RevenueFree cash flow
| Q4 FY2026 | Jun 30, 2026 | $321M | 0.36 | $86.94M | 65.8% | 23.1% | 17.0% |
| Q3 FY2026 | Mar 31, 2026 | $311M | 0.32 | $77.58M | 66.9% | 24.2% | 16.4% |
| Q2 FY2026 | Dec 31, 2025 | $296M | 0.24 | $76.49M | 64.6% | 18.4% | 12.8% |
| Q1 FY2026 | Sep 30, 2025 | $287M | 0.24 | $22.22M | 65.6% | 16.6% | 13.3% |
| Q4 FY2025 | Jun 30, 2025 | $317M | -0.11 | $93.31M | 62.7% | -7.5% | -5.6% |
| Q3 FY2025 | Mar 31, 2025 | $316M | 0.14 | $31M | 67.9% | 12.2% | 7.1% |
| Q2 FY2025 | Dec 31, 2024 | $297M | 0.22 | $77.53M | 65.3% | 16.0% | 11.7% |
| Q1 FY2025 | Sep 30, 2024 | $289M | 0.21 | $54.72M | 63.2% | 13.8% | 11.6% |
| Q4 FY2024 | Jun 30, 2024 | $306M | 0.25 | $57.52M | 66.4% | 15.0% | 13.3% |
| Q3 FY2024 | Mar 31, 2024 | $303M | 0.31 | $64.55M | 67.4% | 22.1% | 16.2% |
| Q2 FY2024 | Dec 31, 2023 | $273M | 0.17 | $68.25M | 64.8% | 13.9% | 10.1% |
| Q1 FY2024 | Sep 30, 2023 | $277M | 0.31 | $45.79M | 66.9% | 20.2% | 18.4% |